Kymera Therapeutics Inc (KYMR) is around the middle of the Biotechnology industry according to InvestorsObserver. KYMR received an overall rating of 59, which means that it scores higher than 59 percent of all stocks. Kymera Therapeutics Inc also achieved a score of 66 in the Biotechnology industry, putting it above 66 percent of Biotechnology stocks. Biotechnology is ranked 21 out of the 148 industries.
KYMR has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on KYMR!